Metraipolis › archive › dc_3140dd5ada15
Do Serum Brain Biomarkers Differentiate the Hemorrhagic Head Injury Lesion Phenotypes? An Interim Analysis of an On-Going Randomized Clinical Trial — Europe PMC PMID:41898376
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41898376
- DOI
- 10.3390/biomedicines14030732
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T01:41:36.564Z
- SHA-256 of the archived text
242667b7ec2f63340a3045d5d16daada3ea6398927f52384d4999e2aef60c737- Stable URL of this page
https://metraipolis.com/documento/dc_3140dd5ada15
How to cite
Do Serum Brain Biomarkers Differentiate the Hemorrhagic Head Injury Lesion Phenotypes? An Interim Analysis of an On-Going Randomized Clinical Trial — Europe PMC PMID:41898376 — Europe PMC (en), https://europepmc.org/article/MED/41898376 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3140dd5ada15 (Metraipolis archive dc_3140dd5ada15, sha256 242667b7ec2f63340a3045d5d16daada3ea6398927f52384d4999e2aef60c737)
BibTeX
@misc{dc3140dd5ada15,
title = {Do Serum Brain Biomarkers Differentiate the Hemorrhagic Head Injury Lesion Phenotypes? An Interim Analysis of an On-Going Randomized Clinical Trial — Europe PMC PMID:41898376},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41898376},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3140dd5ada15; sha256 242667b7ec2f63340a3045d5d16daada3ea6398927f52384d4999e2aef60c737},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898376. Agents can read the archived copy with the MCP tool read_document.